David A. Eastmond

9.2k citations

103 papers · 7.3k indexed · 3 hit papers · h-index 40

Cancer Research top 0.2%
Molecular Biology top 2%
Health, Toxicology and Mutagenesis top 0.2%
Plant Science top 2%
Oncology top 5%

Co-authors: James D. Tucker Martyn T. Smith Micheline Kirsch‐Volders Michael Fenech Hannu Norppa Jordi Surrallés D.S. Rupa Mary K. Manibusan
Topics: Carcinogens and Genotoxicity Assessment (53 papers)DNA Repair Mechanisms (32 papers)Effects and risks of endocrine disrupting chemicals (14 papers)
Cited by: Cancer Research Chemical Health and Safety Health, Toxicology and Mutagenesis
Journals: Ecology Cancer Environmental Health Perspectives
Partner nations: United States Germany Japan

In The Last Decade

David A. Eastmond

102 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells

2010 940 citations Michael Fenech, Micheline Kirsch‐Volders et al. Mutagenesis profile →
Identification of aneuploidy‐inducing agents using cytokinesis‐blocked human lymphocytes and an antikinetochore antibody

1989 583 citations David A. Eastmond, James D. Tucker Environmental and Molecular Mutagenesis profile →
Report from the in vitro micronucleus assay working group

2003 510 citations Micheline Kirsch‐Volders, Toshio Sofuni et al. Mutation Research/Genetic Toxicology and Environmental Mutagenesis profile →

Peers

Countries citing papers authored by David A. Eastmond

Since Specialization

Citations

This map shows the geographic impact of David A. Eastmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Eastmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Eastmond more than expected).

Fields of papers citing papers by David A. Eastmond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Eastmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Eastmond. The network helps show where David A. Eastmond may publish in the future.

Co-authorship network of co-authors of David A. Eastmond

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Eastmond. A scholar is included among the top collaborators of David A. Eastmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Eastmond. David A. Eastmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targets and mechanisms of chemically induced aneuploidy. Part 1 of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Anthony M. Lynch,David A. Eastmond,Azeddine Elhajouji,Roland Froetschl,Micheline Kirsch‐Volders,Francesco Marchetti,Kenichi Masumura,Francesca Pacchierotti,Maik Schuler,David Tweats	28
2	Role of aneuploidy in the carcinogenic process: Part 3 of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·David Tweats,David A. Eastmond,Anthony M. Lynch,Azeddine Elhajouji,Roland Froetschl,Micheline Kirsch‐Volders,Francesco Marchetti,Kenichi Masumura,Francesca Pacchierotti,Maik Schuler	18
3	Concordance of Transcriptional and Apical Benchmark Dose Levels for Conazole-Induced Liver Effects in Mice 2013 ·Toxicological Sciences ·Virunya S. Bhat,Susan Hester,Stephen Nesnow,David A. Eastmond	48
4	A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II 2012 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·(unknown),L. Hasegawa,David A. Eastmond	7
5	Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus) 2011 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Sheila M. Galloway,Elisabeth Lorge,Marilyn J. Aardema,David A. Eastmond,Mick D. Fellows,Robert H. Heflich,David Kirkland,Dan D. Levy,Anthony M. Lynch,Daniel Marzin,Takeshi Morita,Maik Schuler,Günter Speit	36
6	Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cellsbreakdown → 2010 ·Mutagenesis ·Michael Fenech,Micheline Kirsch‐Volders,A.T. Natarajan,Jordi Surrallés,Jimmy W. Crott,James M. Parry,Hannu Norppa,David A. Eastmond,James D. Tucker,Philip Thomas	940
7	Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities—Report from an ECVAM workshop 2009 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Stefan Pfuhler,David Kirkland,Peter Kasper,Makoto Hayashi,Philippe Vanparys,Paul L. Carmichael,Stephen D. Dertinger,David A. Eastmond,Azeddine Elhajouji,Cyrille Krul,Andreas Rothfuß,(unknown),Andrew J. Smith,(unknown),(unknown),Jan van Benthem,Raffaella Corvi	76
8	Topoisomerase II inhibition by myeloperoxidase-activated hydroquinone: A potential mechanism underlying the genotoxic and carcinogenic effects of benzene 2005 ·Chemico-Biological Interactions ·David A. Eastmond,(unknown),L. Hasegawa	39
9	Induction of cell proliferation, micronuclei and hyperdiploidy/polyploidy in the mammary cells of DDT- and DMBA-treated pubertal rats 2005 ·Environmental and Molecular Mutagenesis ·(unknown),Shambhu Roy,Albert Tousson,Stephen Barnes,(unknown),David A. Eastmond	13
10	Chromosome breakage is primarily responsible for the micronuclei induced by 1,4-dioxane in the bone marrow and liver of young CD-1 mice 2005 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Shambhu Roy,(unknown),David A. Eastmond	31
11	Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance 2004 ·Cancer ·Andrew Olaharski,David A. Eastmond	13
12	Report from the in vitro micronucleus assay working groupbreakdown → 2003 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Micheline Kirsch‐Volders,Toshio Sofuni,Marilyn J. Aardema,Silvio Albertini,David A. Eastmond,Michael Fenech,Motoi Ishidate,Stephan Kirchner,Elisabeth Lorge,Takeshi Morita,Hannu Norppa,Jordi Surrallés,(unknown),Akihiro Wakata	510
13	Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes 1999 ·Mutagenesis ·(unknown),Maik Schuler,David A. Eastmond	14
14	Targeted breakage of paracentromeric heterochromatin induces chromosomal instability 1998 ·Mutagenesis ·Leslie E. Smith,(unknown),L. Hasegawa,David A. Eastmond,Andrew J. Grosovsky	14
15	Evidence for oxidative metabolism in the genotoxicity of 2-nitronaphthalene and 2-nitrodibenzopyranone 1997 ·Environmental and Molecular Mutagenesis ·Jennifer C. Sasaki,Janet Arey,David A. Eastmond	1
16	Bimolane: in vitro inhibitor of human topoisomerase II 1997 ·Cancer Letters ·Christopher E. Frantz,Heather M. Smith,(unknown),Andrew J. Grosovsky,David A. Eastmond	8
17	Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects 1995 ·Carcinogenesis ·Hongwei Chen,David A. Eastmond	80
18	Synergistic increase in chromosomal breakage within the euchromatin induced by an interaction of the benzene metabolites phenol and hydroquinone in mice 1995 ·Carcinogenesis ·Hongwei Chen,David A. Eastmond	47
19	Induction of micronuclei and aneuploidy by the quinone-forming agents benzene and o-phenylphenol 1993 ·Toxicology Letters ·David A. Eastmond	31
20	Metabolism of phenylhydroquinone by prostaglandin (H) synthase: possible implications in o-phenylphenol carcinogenesis 1991 ·Carcinogenesis ·Prema Kolachana,Vangala V. Subrahmanyam,David A. Eastmond,Martyn T. Smith	19

About David A. Eastmond

David A. Eastmond is a scholar working on Cancer Research, Chemical Health and Safety and Toxicology, having authored 103 papers that have together received 7.3k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (53 papers), DNA Repair Mechanisms (32 papers) and Effects and risks of endocrine disrupting chemicals (14 papers). The work is most often cited by research in Cancer Research (3.5k citations), Chemical Health and Safety (132 citations) and Health, Toxicology and Mutagenesis (2.0k citations). David A. Eastmond has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include James D. Tucker, Martyn T. Smith, Micheline Kirsch‐Volders, Michael Fenech, Hannu Norppa, Jordi Surrallés, D.S. Rupa, Mary K. Manibusan, L. Hasegawa and Luoping Zhang. Their work appears in journals such as Ecology, Cancer and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact